Skip to main content

Cardiovascular Medicine Grand Rounds

Cardiovascular Medicine Grand Rounds are Fridays from 8:00 am - 9:00 am.

Please contact Margo Relaford for questions or to be added to our email list.


Upcoming Grand Rounds


ACTRI front

Holiday Break

Break until 1/6/2023




AY 2022-2023 Grand Rounds (past)

  • November 4, 2022

    November 4, 2022

    “Picture perfect: the role of coronary CT in patients with stable chest pain”

    Andrew Lin, MD & Emily Nguyen, MD/PhD
    Cardiovascular Medicine Fellows
    University of California San Diego

    ACTRI Auditorium (Rm 1W-210) & Zoom

  • October 28, 2022

    October 28, 2022

    “Contemporary Perspectives on Moderate Aortic Stenosis”

    Dr. Nicolas Van Mieghem, MD, PhD
    Erasmus University Rotterdam

    ACTRI Auditorium (Rm 1W-210) & Zoom

  • October 21, 2022

    October 21, 2022

    "Cardiac MRI in Patients with Chest Pain-State of the Art and the Future”

    Matthias G. Friedrich MD, FESC FACC, FSCMR
    Cardiologist, Chief, Cardiovascular Imaging
    McGill University Health Centre
    Scientific Director, Courtois Cardiovascular Signature Program

    ACTRI Auditorium (Rm 1W-210) & Zoom

  •  October 14, 2022

    October 14, 2022

    “Evolution of anti-obesity therapy: the birth of another chronic cardiometabolic disease ”

    Eduardo Grunvald, MD, FACP
    Medical Director, Center for Advanced Weight Management
    UCSD Bariatric and Metabolic Institute
    Clinical Professor of Medicine
    Divisions of General Internal Medicine and Minimally Invasive Surgery

    ACTRI Auditorium (Rm 1W-210) & Zoom

  •  October 7, 2022

    October 7, 2022

    “REVIVE-ing Myocardium: A deeper look into the REVIVED-BCIS Trial”

    Dr. Daniel Chu & Dr. Musa Shakoor
    Cardiology Fellows
    University of California San Diego

    ACTRI Auditorium (Rm 1W-210) & Zoom

  • September 30, 2022

    September 30, 2022

    "Neurosurgical Innovation in the Academic Ecosystem: Challenges, Opportunities, and the UC San Diego Experience”

    Dr. Alexander Khalessi
    Professor & Chair
    Neurological Surgery
    University of California San Diego

    ACTRI Auditorium (Rm 1W-210) & Zoom

  • September 23, 2022

    September 23, 2022

    "Cardiovascular Care for the LGBTQ+ Community Today”

    Dr. Matthew Carazo
    Assistant Professor of Medicine
    Adult Congenital Heart Program
    University of California San Diego

    ACTRI Auditorium (Rm 1W-210) & Zoom

  • September 16, 2022

    September 16, 2022

    ”A Valorous Effort: A Breakthrough in HOCM Therapy”

    Dr. Tania Saul & Dr. Sonya John
    Cardiovascular Medicine Fellows
    University of California San Diego

    ACTRI Auditorium (Rm 1W-210) & Zoom

  •  September 9, 2022

    September 9, 2022

    ”Challenges and Opportunities in Cardiovascular Clinical Trials”

    Ori Ben-Yehuda, MD, FACC
    Clinical Professor of Medicine, UC San Diego
    Executive Director, Cardiovascular Research Foundation

    ACTRI Auditorium (Rm 1W-210) & Zoom

AY 2021-2022 Grand Rounds (past)

  • May 27, 2022

    May 27, 2022

    The Evolving Landscape of Hyperlipidemia Management in 2022 (Dr. Chindhy)
    The Predictive Value of Respiratory Rate: Beyond “Shortness of Breath (Dr. Torres Barba)

    Shahzad Chindhy, MD & David Torres Barba, MD, PhD
    Cardiovascular Medicine Fellows
    University of California San Dieg

  •  May 20, 2022

    May 20, 2022

    Cardiac Genetic Evaluation: Is it practical or purely academic? (Dr. Quan Bui)
    The Role of Coronary Computed Tomography Angiography (CCTA) (Dr. Kevin Ting)

    Quan Bui, MD & Kevin Ting, MD
    Cardiovascular Medicine Fellows
    University of California San Diego

  •  May 13, 2022

    May 13, 2022

    2018 ACHD Guidelines: Summary and Challenges

    Arwa Saidi, MB, BCh, FACC
    Professor, Department of Pediatrics & Internal Medicine
    University of Florida

  •  May 6, 2022

    May 6, 2022

    New and Emerging Lipid-Lowering Therapies

    Michael Wilkinson, MD
    Assistant Professor of Medicine
    Cardiovascular Diseases
    University of California San Diego

  • April 29, 2022

    April 29, 2022

    Radiation Associated Cardiac Disease: A Gray Area (Dr. Azcarate)


    Medical Education: 3D take on new opportunities (Dr. Bhatia)

    Dr. Patrick Azcarate & Dr. Prerana Bhatia
    Cardiovascular Medicine Fellows
    University of California San Diego

  •  April 22, 2022

    April 22, 2022

    The Rationale for Coronary Revascularization in Stable Ischemic Heart Disease: The CHIP Premise

    Ajay J. Kirtane, MD, SM
    Professor of Medicine at the Columbia University Medical Center
    Chief Academic Officer, Columbia Interventional Cardiovascular Care
    Director, NYP/Columbia Cardiac Catheterization Laboratories

  • April 15, 2022

    April 15, 2022

    Cardio-Obstetrics: An Emerging Field in Cardiology

    Candice Silversides, MD
    Professor of Medicine, University of Toronto
    Editor-in-Chief, JACC Advances

  • April 8, 2022

    April 8, 2022

    Female Specific Risk Factors That Enhance Women’s Cardiovascular Risk Across the Lifespan

    Erin D. Michos, MD, MHS, FAHA, FACC, FASE, FASPC
    Associate Professor, Division of Cardiology
    Associate Director of Preventive Cardiology
    John Hopkins, School of Medicine

  • April 1, 2022

    April 1, 2022

    Shockingly Effective: The Use of Subcutaneous ICD

    Dr. Omar Aldaas & Dr. Andrew Lin
    Cardiovascular Medicine Fellows
    University of California San Diego

  • March 18, 2022

    March 18, 2022

    SGLT2 Inhibitors - Sweet Success for the Diabetic Heart

    Sunder Mudaliar, MD
    Clinical Professor of Medicine
    University of California San Diego
    Staff Physician VA San Diego Healthcare System
  • March 11, 2022

    March 11, 2022

    Patient-Reported Outcomes in Heart Failure: Using the Patients’ Voice in Clinical Trials, Quality Assessment and Clinical Care

    John Spertus, MD, MPH, FACC, FAHA
    Daniel Lauer/Missouri Endowed Chair and Professor University of Missouri – Kansas City
    Clinical Director of Outcomes Research
    Saint Luke’s Mid America Heart Institute
  • March 4, 2022

    March 4, 2022

    Robotic Cardiovascular Interventions

    Ehtisham Mahmud, MD, FACC, MSCAI
    Edith and William Perlman Chair in Cardiology
    Professor and Division Chief, Cardiovascular Medicine
    Executive Director, UCSD Cardiovascular Institute-Medicine
    University of California, San Diego
  • February 25, 2022

    February 25, 2022

    The CLICK Trial: Reconsidering Chlorthalidone in CKD4

    Dr. Candace Jackson & Dr. Bryan Wu
    Cardiovascular Medicine Fellows
    University of California San Diego

  • February 18, 2022

    February 18, 2022

    The Latest Outcomes in CABANA

    Douglas L. Packer, MD
    Professor of Medicine, Mayo
    John M. Nasseff, Sr., Professorship in Cardiology
    Director, Interventional Cardiac Electrophysiology Research Laboratories

  • February 11, 2022

    February 11, 2022

    Amyloidosis Center of Excellence: The UC San Diego Health Experience

    Marcus Anthony Urey, MD
    Assistant Professor of Medicine
    University of California, San Diego
  • February 4, 2022

    February 4, 2022

    PVCs, Cardiomyopathies and Sudden Death

    William Stevenson, MD
    Professor of Medicine, Vanderbilt University
  • January 28, 2022

    January 28, 2022

    Limits of the New Heart Failure ‘Paradigm’? Reconsidering Sacubitril/Valsartan in Advanced Heart Failure and the Story of One Trial’s Struggle With the COVID Pandemic: The LIFE Trial

    Dr. Alison Brann & Dr. John Power
    Cardiovascular Medicine Fellows
    University of California San Diego

  • January 21, 2022

    January 21, 2022

    Transcatheter Mitral Valve Replacement

    Mayra Guerrero MD, FACC, FSCAI, FESC Professor of Medicine, Mayo Clinic College of Medicine
    Associate Program Director, Cardiovascular Medicine Fellowship
    Vice Chair of Diversity and Inclusion, Department of Cardiovascular Medicine
  • January 14, 2022

    January 14, 2022

    New Standards for the Medical Care of Heart Failure

    Dr. Jim Januzzi, Mass General
    Hutter Family Professor of Medicine,
    Harvard Medical School
  • January 7, 2022

    January 7, 2022

    A Medley of Two Topics about Thinking Differently

    Harlan M. Krumholz, MD, SM
    Harold H. Hines, Jr. Professor of Medicine
    Yale School of Medicine
    Director, Center for Outcomes Research and Evaluation
    Yale New Haven Hospital
  • November 19, 2021

    November 19, 2021

    ECPR and Refractory Cardiac Arrest 

    Demetri Yannopoulos, MD
    Professor of Medicine & Emergency Medicine
    Director, Center for Resuscitation Medicine
    Interventional Cardiology 
    University of Minnesota
  • November 12, 2021

    November 12, 2021

    Is One Month Enough? Abbreviated DAPT in High Risk Bleeding Patients Following PCI. Journal Club

    Gary Ma, MD & Tania Saul, MD
    Cardiovascular Medicine Fellows
    University of California, San Diego
  • November 5, 2021

    November 5, 2021

    Long Covid and POTS: New Insights and Therapies

    Pam R. Taub, MD, FACC, FASPC
    Profesor of Medicine
    Director of Step Family Foundation Cardiovascular Rehabilitation and Wellness Center
    UC San Diego Health System 
  • October 29, 2021

    October 29, 2021

    Functional Alterations of Coronary Circulation

    Professor Filippo Crea
    Editor and Chief, European Heart Journal  Director, Cardiology Unit A. Gemelli Foundation - IRCCS Director, University Department of Cardiovascular and Pneumological  Sciences  Catholic University of the Sacred Heart, Rome Italy
  • October 19, 2021

    October 19, 2021

    Multimodality Imaging Guided Therapy: New Therapeutics in Pericarditis

    Allan L. Klein MD, FRCP (C), FACC, FAHA, FASE, FESC
    Profesor of Medicine
    Cleveland Clinic Lerner College of Medicine of Case Western University
     Director, Center for the Diagnosis and Treatment of Pericardial Disease
     Section of Cardiovascular Imaging, Department of Cardiovascular Medicine
     Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio
  • October 15, 2021

    October 15, 2021

    Improving Risk Assessment and Streamlining the Management of Atrial Fibrillation: Easy as ABC...

    Gregory YH Lip, MD, FRCP [London Edinburgh Glasgow], DFM, AFHEA, FACC, FESC, FEHRA  
    Price-Evans Chair of Cardiovascular Medicine, 
     University of Liverpool, United Kingdom; 
     Distinguished Professor, Faculty of Medicine,  Aalborg University, Denmark; 
     Adjunct Professor, Yonsei University, Seoul, South Korea
     Adjunct Professor, Seoul National University, South Korea
  • October 8, 2021

    October 8, 2021

    Update on Omega-3 Fatty Acids

    Deepak Bhatt , MD, MPH
     Executive Director of Interventional Cardiovascular Programs 
     Brigham and Women's Hospital Heart & Vascular Center 
     Professor of Medicine, Harvard Medical School
  • October 1, 2021

    October 1, 2021

    Antiplatelet Therapy After PCI: An Overview of the Latest Evidence

    Roxana Mehran, MD, FACC, FAHA, MSCAI, RESC
    Professor  of Medicine in Cardiology and Population Health Science and Policy
     Mount Sinai Professor in Cardiovascular Clinical Research and Outcomes 
     Director of Interventional Cardiovascular Research and Clinical Trials
  • September 24, 2021

    September 24, 2021

    DoReMi Trial: Music to our Ears? Or a Cacophony of Sound? 

    Antoinette Birs, MD & Anoop Muniyappa, MD
    Cardiovascular Medicine Fellows
    University of California, San Diego
  • September 17, 2021

    September 17, 2021

    Finding the Vulnerable Plaque to Prevent Heart Attack

    David Erlinge, MD. PhD, FESC, FACC
    Department Head of Cardiology 
    Lund University, Sweden 

AY 2020-2021 Grand Rounds (past)

  • May 28, 2021

    May 28, 2021

    STEMI: Cardioprotection During Myocardial Reperfusion               Dr. Govea

    Subclinical CVD and Primary Prevention: My Year in the T32        Dr. Bhatia 

     Alayn Govea, MD  & Harpreet Bhatia, MD 
     Cardiovascular Medicine Fellows
     University of California, San Diego
  • May 14, 2021

    May 14, 2021

    Clinical Staging in Hypertrophic Cardiomyopathy: Approach to Risk Stratification and Management

    Jorge Silva Enciso, MD
    Associate Clinical Professor of Medicine
    Director, Hypertrophic Cardiomyopathy Program
    Heart Failure, Mechanical Circulatory Support and Transplant Cardiology 
  • May 10, 2021

    May 10, 2021

    Surgical and Interventional Therapeutics for CTEPH: History and UCSD's Experience

    Contemporary Updates on Venoarterial Extracorporeal Membrane Oxygenation 

    Jason Duran, MD, PhD & Daniel Mangels, MD
    Cardiovascular Medicine Fellows
    University of California, San Diego 
  • May 7, 2021

    May 7, 2021

    Surgical and Interventional Therapeutics for CTEPH: History and UCSD's experience

    Methamphetamine Associated Heart Failure (MethHC): A Unique UCSD Experience 

    Abdullah Almasoud, MD & Marin Nishimura, MD
    Cardiovascular Medicine Fellows
    University of California, San Diego 
  • April 30, 2021

    April 30, 2021

    The Endothelium in Health and Disease

    John Keaney, MD
    Chief, Division of Cardiovascular Medicine
    Brigham and Women’s Hospital
    Victor J. Dzau Professor of Medicine
    Harvard Medical School
  • April 23, 2021

    April 23, 2021

    Autonomic Nervous System and Cardiac Arrhythmia

    Peng-Sheng Chen, MD
    Editor-in-Chief,Heart Rhythm Journal
    Burns&Allen Chair in Cardiology Research
    Staff Physician III
    Department of Cardiology, Smidt Heart Institute
    Cedars-Sinai Medical Center
  • April 16, 2021

    April 16, 2021

    Heart Failure With Mildly Reduced and Normal Ejection Fraction

    Scott D. Solomon, MD,
    The Edward D. Frohlich Distinguished Chair,
    Professor of Medicine, Harvard Medical School,
    Brigham and Women’s Hospital
  • April 9, 2021

    April 9, 2021

    Cardiorenal Effects of SGLT2 Inhibitors: A New Tool in the Cardiologist Toolbox

    Darren K. McGuire, MD, MHSc
    Distinguished Teaching Professor of Medicine
    University of Texas Southwestern Medical Center
    Parkland Health and Hospital System
    Dallas, TX
  • April 2, 2021

    April 2, 2021

    Clinical Innovation and the Management of Cardiac Arrhythmias

    William Sauer, MD
    Section Chief Cardiac Arrhythmia Service
    Brigham and Women’s Hospital
    Harvard Medical School
  • March 19, 2021

    March 19, 2021

    PARA-Gone With the Wind? Finding Significance in a “Negative” Trial

    Patrick Azcarate, MD & Omid Behnamfar, MD
    Cardiovascular Medicine Fellows,
    University of California, San Diego
  • March 12, 2021

    March 12, 2021

    Hypertrophic Cardiomyopathy in 2021 and Beyond

    Carolyn Ho MD
    Medical Director, Cardiovascular Genetics Center
    Brigham and Women's Hospital
  • March 5, 2021

    March 5, 2021

    Medical Decision Making in Heart Failure: Engaging Patients

    Larry Allen, MD, MHS
    Professor of Medicine, University of Colorado
  • February 26, 2021

    February 26, 2021

    The Ischemia Trial, an Updated Look at Stable Ischemic Heart Disease

    Kevin Ting, MD & Antoinette Birs, MD
    Cardiovascular Medicine Fellows,
    University of California, San Diego
  • February 9, 2021

    February 9, 2021

    Demystifying the Tricuspid Valve: Anatomy, Pathophysiology and Treatment

    Rebecca T. Hahn, MD, FACC, FESC, FASE
    Professor of Medicine, Columbia University Medical Center
  • February 5, 2021

    February 5, 2021

    Rate or Rhythm Control in Atrial Fibrillation: Why? When? How?

    Vivek Reddy, MD
    Helmsley Trust Professor of Medicine Director,
    Cardiac Electrophysiology Mount Sinai School of Medicine
  • January 29, 2021

    January 29, 2021

    Cardiac Amyloidosis: The Future is Now

    Ahmad Masri, MD, MS
    Director, Hypertrophic Cardiomyopathy Center
    Assistant Professor of Medicine
    Oregon Health and Science University